Biochemistry major Jonas Muller ’27 has earned plaudits abroad this summer after unveiling surprising findings on the environmental impact of antibiotic drugs during a poster competition at the International Society for Pharmacoepidemiology (ISPE) annual conference —...
A dog’s pain medication, a grandparent’s pill organizer, even a discarded tissue: Rutgers Health research reveals they’re all potential sources of opioid poisoning for young children. Researchers at the New Jersey Poison Control Center examined 230 cases...
Rutgers received a $3.2 million grant from the National Institutes of Health to study the impact of micronanoplastics on the digestive system. The byproduct of environmental and industrial processes, micro- and nano-scale plastic particles and fibers increasingly...
New Dashboards and Reporting Capabilities Through OnCore Jonathan Carter, MBS Business Systems Analyst Clinical Trials Office We are back with another joint work group call. Jonathan will show the new reporting capabilities through OnCore, Rutgers’ clinical trial...
Rutgers Health researchers will enroll primary or secondary progressive multiple sclerosis (p-MS) patients to see if an engineered immune cell therapy can halt the progression of the autoimmune disease. Mistargeted attacks by the body’s immune system and active...
